NEUROVASCULAR DIAGNOSTICS, INC.
Better Care Through Personalized Medicine
BUFFALO, United States · Founded 2018 · $2.9M raised
- Headquarters
- BUFFALO, New York
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2G
- Website
- nvdiag.com
- Total Funding
- $2.9M
- Last Round
- $2.9M GrantJan 2024
- Rounds
- 1
About
Neurovascular Diagnostics is a University at Buffalo spinout developing AneuScreen, a low-cost blood diagnostic to detect unruptured brain aneurysms. The test identifies gene expression markers in blood cells altered by aneurysm-driven inflammation, enabling affordable mass screening for a condition that affects millions of Americans with little early warning.
Summary
NEUROVASCULAR DIAGNOSTICS, INC. is a Biotech company based in BUFFALO, United States, founded in 2018. It has raised $2.9M in total across 1 round, most recently a $2.9M Grant round in Jan 2024. Investors include NIH.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2024
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.